(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PRGF - ENDORET

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PRGF - ENDORET

ST13

US500000079111229

Classe

5, 9, 10, 42

Pedido

79111229

Registro

4381564

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

57

Atualização mais recente

21/12/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 42

Data de depósito

18/10/2011

Data de registro

13/08/2013

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/03/2024

Última transação

01/03/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

ES

Examinador

VERHOSEK, WILLIAM T

Unidade examinadora

M50

Titulares e representantes

Titulares

BIOTECHNOLOGY INSTITUTE, S.L.

Representantes

JOSE MARIA ARRUFAT ARRUFAT GRACIA PLLC

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Sanitary preparations for medical purposes; materials for dressingsgauze; biomaterials for medical purposesimplants comprising living tissue; pharmaceutical preparationsin particularampoules containing pharmaceutical substances to be mixed with platelet-rich plasma in order to generate autologous thrombin; medicated bandage compresses; adhesive tapes for sanitary purposesdressings; preparations for regenerating bone tissue; medical kits consisting of pharmaceutical preparations in the form of active principles for mixing with blood plasmamaterials for dressingbandages and tape for sanitary purposes and adhesive plasters for woundsall of the above for use in the production of blood plasma

Classe 9

Apparatus for centrifuging bloodlaboratory centrifuges ; furnaces for laboratory use; pippettes

Classe 10

Dropping pipettes for medical purposes; instruments for medical purposes for capturingdispensing and transferring fluids in general and blood plasma in particularespeciallyinstruments made up of a cannula through which blood plasma is captured and a tube to which the captured blood plasma is directly transferred; medical apparatus and instruments for dental purposesdental implantsdental instruments for use in surgery; apparatus for analyzing bloodcontainer tubes for bloodlaboratory apparatus for treating bloodcontainer tubes for blood samplescompressors for medical purposes and needles for medical purposesall of the above included in a kit for producing blood plasma

Classe 42

Scientific and technological services and transfer of technical expertisescientific researchanalysistesting and information in connection with bone and tissue regeneration methods

Publicações

Histórico de despachos e eventos da marca no USPTO.

57 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

21/12/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

20/11/2024

INPC

INVALIDATION PROCESSED

20/11/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

02/11/2024

C71T

CANCELLED SECTION 71

01/03/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

19/01/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

13/08/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/11/2021

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

25/10/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/10/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/10/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/10/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/10/2019

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

28/06/2019

INPC

INVALIDATION PROCESSED

28/06/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

17/06/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

17/10/2018

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

17/10/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

17/10/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

02/10/2018

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

13/08/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

26/04/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

20/11/2015

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

24/12/2014

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

19/12/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

21/02/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

13/11/2013

FIMP

FINAL DISPOSITION PROCESSED

13/11/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

13/11/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

13/08/2013

GPNX

NOTIFICATION PROCESSED BY IB

21/07/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

28/05/2013

PUBO

PUBLISHED FOR OPPOSITION

28/05/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/05/2013

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/05/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/05/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/04/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/04/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/04/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/04/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/04/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

26/10/2012

GNRT

NON-FINAL ACTION E-MAILED

26/10/2012

CNRT

NON-FINAL ACTION WRITTEN

26/10/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/10/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/10/2012

ALIE

ASSIGNED TO LIE

17/10/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/10/2012

RFNT

REFUSAL PROCESSED BY IB

19/05/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/04/2012

RFRR

REFUSAL PROCESSED BY MPU

30/04/2012

MAFR

APPLICATION FILING RECEIPT MAILED

28/04/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

26/04/2012

CNRT

NON-FINAL ACTION WRITTEN

25/04/2012

DOCK

ASSIGNED TO EXAMINER

24/04/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/04/2012

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

21/04/2012

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PRGF - ENDORET ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.